We would love to hear your thoughts about our site and services, please take our survey here.
Who is the person(s) behind this Group - as interested to join, hopefully this Group will help shareholders that are currently in limbo, and not having full details of all the speculation around the company board members - current & previous.
ImmuPharma raises £6.5m through discounted equity placing
2 September 2020 | 09:14am
StockMarketWire.com - Drug discovery and development company ImmuPharma said it had raised £6.5m through the placing of shares at a discount.
The company reported an oversubscribed placing of 59,090,909 new shares at a price of 11p, representing a 27.6% discount to the 7-day volume weighted average price of its shares on 1 September 2020.
The proceeds from the placing were expected to be approximately £5.9m and would be used to progress the company's therapeutic pipeline including one of its new developments, BioAMP-B, a peptide-based drug that offers a potential treatment for many serious and life threatening fungal infections such as aspergillosis (lung infection).
Taking into account existing cash resources and the expected net proceeds, the company said it expected to have sufficient cash resources to fund operations through the end of 2023.
https://www.lse.co.uk/SharePrice.asp?shareprice=SPC&share=Uk-Spac
Hi DellNRoders
No worries, I only have a very small holding here, like you and I guess all other shareholders hope its going to be worth the wait, surely the management will find something to RTO. I for one will be following up my email to them if they fail and it turns out that's its just been a life style prolongment for them (if you know what I mean). But I am also optimistic of a positive outcome here.
Anyway not too long to wait now - best of luck to all shareholders.
Hi DellNRoders
As a cash shell the Company is required to make an acquisition or acquisitions which constitute a reverse takeover under AIM Rule 14 within six months of 3 March 2121 or be re-admitted to trading on AIM as an investing company under the AIM Rules (which would require the raising of at least £6m) failing which the Company's Ordinary Shares would be suspended from trading on AIM.
Above taken from:
http://www.ukspacplc.com/index.html
So RTO if I am correct has to be actioned by 2nd Sept 2021 latest, that's within the 6 months from 3rd March 2021
https://www.investorschronicle.co.uk/news/2021/07/07/playing-the-e-sports-growth-story/
Hi I emailed the company via the website - and received a reply, which I thought would be nice to share with fellow shareholders:
I asked about lack of news/information/update on where they are with a RTO:
Whilst I appreciate your concern (a lack on information could mean that the directors are not actively looking after the interest of shareholders) I have to tell you we work within an environment where we may only provide news to s happened. If we breach that rule we face suspension.
The Company, as Mountfield, was a construction company. We knew we would not seek a target in that area for a number of reasons but we were/are not set on buying on one particular sector - we are looking for the purchase that we think will bring the best returns for shareholders and there are a large number of sectors - medical, technical, IT etc will provide opportunities.
Do not be disturbed by silence but be assured that the directors are working hard to find a suitable RTO investment and that as soon as we have signed a agreement to purchase we will announce it. The first you are likely to hear of it will be when an agreement to purchase is announced to the Stock Exchange and to shareholders.
Best & GLA - mdle4